143 related articles for article (PubMed ID: 3247475)
1. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines].
Gałazka A
Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475
[No Abstract] [Full Text] [Related]
2. Recent trends in the developments of bacterial vaccines.
Lindberg AA; Pillai S
Dev Biol Stand; 1996; 87():59-71. PubMed ID: 8854003
[No Abstract] [Full Text] [Related]
3. [Genetic engineering and trends in the research on new vaccines].
Hofnung M
C R Seances Soc Biol Fil; 1988; 182(2):141-57. PubMed ID: 2461790
[TBL] [Abstract][Full Text] [Related]
4. Bacterial infectious disease control by vaccine development.
Curtiss R
J Clin Invest; 2002 Oct; 110(8):1061-6. PubMed ID: 12393839
[No Abstract] [Full Text] [Related]
5. Existing antibacterial vaccines.
Mendoza N; Ravanfar P; Satyaprakash A; Pillai S; Creed R
Dermatol Ther; 2009; 22(2):129-42. PubMed ID: 19335724
[TBL] [Abstract][Full Text] [Related]
6. Human vaccines.
Ada GL
Dev Biol Stand; 1994; 82():181-8. PubMed ID: 7958473
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the development of live, attenuated bacterial vectors.
Roland KL; Tinge SA; Killeen KP; Kochi SK
Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
[TBL] [Abstract][Full Text] [Related]
8. Bacterial polysaccharide-protein conjugate vaccines.
Finn A
Br Med Bull; 2004; 70():1-14. PubMed ID: 15339854
[TBL] [Abstract][Full Text] [Related]
9. Disease prevention by immunization and chemoprophylaxia.
J Indiana State Med Assoc; 1975 Jun; 68(6):462-6. PubMed ID: 1127246
[No Abstract] [Full Text] [Related]
10. Genetically engineered vaccines: problems and promises.
Brown F; Dougan G; Snary D
Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
[TBL] [Abstract][Full Text] [Related]
11. Compliance with immunizations in splenectomized individuals with hereditary spherocytosis.
Grace RF; Mednick RE; Neufeld EJ
Pediatr Blood Cancer; 2009 Jul; 52(7):865-7. PubMed ID: 19214975
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bacterial vaccines.
Unnikrishnan M; Rappuoli R; Serruto D
Curr Opin Immunol; 2012 Jun; 24(3):337-42. PubMed ID: 22541723
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
Oliveira ML; Arêas AP; Ho PL
Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.
O'Hagan DT
Clin Pharmacokinet; 1992 Jan; 22(1):1-10. PubMed ID: 1559304
[No Abstract] [Full Text] [Related]
15. [Active immunization and its effect on the epidemic process of childhood infections].
Chudnaia LM; Shekhter AB
Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):70-4. PubMed ID: 3218416
[No Abstract] [Full Text] [Related]
16. [Biotechnology vaccines--development of new disease prevention. Research progress of Biocine in Siena--HIV, herpes, Helicobacter].
Keil TU
Fortschr Med; 1994 Apr; 112(11):53-4. PubMed ID: 8200601
[No Abstract] [Full Text] [Related]
17. Recombinant Salmonella vectors in vaccine development.
Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
[TBL] [Abstract][Full Text] [Related]
18. Miracle vaccines. Advances in genetic engineering are spawning a new generation of powerful disease fighters.
Schrof JM
US News World Rep; 1998 Nov; 125(20):56-9, 62-7. PubMed ID: 10187349
[No Abstract] [Full Text] [Related]
19. Salmonella-based vaccines for infectious diseases.
Kwon YM; Cox MM; Calhoun LN
Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
[TBL] [Abstract][Full Text] [Related]
20. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
Lewis GK
Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
